How Much of a Cancer Drug Is Too Much? Patients, Researchers Challenge FDA-Approved Dosages By Arthur Allen Aug. 20, 2026 +++

https://kffhealthnews.org/health-industry/cancer-drug-immunotherapy-fda-approved-dosages-challenged-keytruda-opdivo/ Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start By Angela Hart Aug. 17, 2026 https://kffhealthnews.org/health-care-costs/gavin-newsom-calrx-state-branded-insulin-generic-biosimilar-drugs-rollout/ You Want To Join a Clinical Trial. Here’s What To Know About the Hurdles. By Michelle Andrews Aug. 19, 2026 https://kffhealthnews.org/health-industry/clinical-trials-patients-hhs-easier-advice-on-how-to-enroll-seriously-ill-cancer/